Navigation Links
Gateway Genomics Achieves Milestone of 100,000 SneakPeek Early Gender DNA Tests Sold
Date:6/3/2019

Gateway Genomics, leading developer of prenatal and pediatric genetic tests, announces sales of over 100,000 SneakPeek Early Gender DNA tests as of this month. SneakPeek is the first non-invasive prenatal test (NIPT) designed solely to determine fetal sex, providing an easy way for families to learn the gender of their baby as early as 9 weeks into pregnancy. The test is available through two channels: 1) An at-home version that lets consumers self-collect a DNA blood sample from the comfort of their home and mail back to SneakPeek Labs for analysis, and 2) A clinical version through participating facilities that collects the sample through a standard blood draw and sends it to SneakPeek Labs for testing. Both options can provide gender results within 1-2 days from sample collection.

“Sales have doubled every year since the test was launched in 2015,” says Gateway Genomics CEO, Chris Jacob. “As our DNA tests become more well-known, we anticipate accelerated demand in the coming years. We’re investing in both our lab testing capacity and the team dedicated to supporting locations that offer our clinical test and expect to surpass 200,000 tests processed by early next year.”

The SneakPeek Early Gender DNA Test by Gateway Genomics is designed to specifically focus on fetal sex and return just one answer – male or female. This enables the test to be run on magnitudes smaller volumes of blood than the typical NIPT, as little as 0.5 mL. SneakPeek returns results as fast as 8 hours after receiving the sample at the lab, with 99.6% accuracy based on peer-reviewed studies.

“This milestone validates the desire new parents have to learn as much about their children as they can, to provide them with the healthiest, best lives they can have,” continues Mr. Jacob. “With this in mind, our aim in the next year is to increase access to the SneakPeek test, adding clinical locations and expanding our international reach in North America and Europe. Longer term, we are developing new product offerings that will give parents the DNA information they need to optimize the health and development of their newborns.”

Gateway Genomics was founded in 2015 on one big idea: Unlock prenatal and pediatric genetic information that gives parents the information they need to provide the best lives for their children. The company continues to develop and produce easy, accessible DNA tests that give families insight into their future children.

About Gateway Genomics

Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 100,000 SneakPeek Early Gender DNA tests have been provided to help new parents bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.

Read the full story at https://www.prweb.com/releases/gateway_genomics_achieves_milestone_of_100_000_sneakpeek_early_gender_dna_tests_sold/prweb16348433.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Allegheny Health Network, Gateway Health Launch New Holistic Program for Patients with Chronic Pain and Opioid Addiction
2. Gateway Health And Wellbridge Health Announce Partnership To Provide Healthcare Innovative Solutions to Gateway Membership
3. Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations
4. Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit
5. Gateway Analytical to Exhibit Pharmaceutical Forensic Services at the American Association of Pharmaceutical Scientist Annual Meeting in San Antonio
6. Murrieta Genomics and Alliance Research Centers Partner to Bring Genomic Sequencing to Clinical Trials
7. Murrieta Genomics and University of California Riverside Partner to Foster Genomic Research and Commercialization
8. uBiome Appoints Dr. Steven Salzberg, PhD, Computational Biology and Genomics Expert, to its Scientific Advisory Board
9. US Capital Global Advises on $2 Million Convertible Note Investment in Toolbox Genomics
10. AccuGenomics Provides an AccuKit to Qura Therapeutics as Part of a Research Collaboration Agreement
11. Global $11.93 Billion Pharmacogenomics Market 2014-2017 & 2024 - Research and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2019)... ... June 19, 2019 , ... ... Practices for Regulatory, Compliance and Quality Professionals, **An FDAnews Webinar**, Monday, June ... the cleanrooms? What are the latest cleaning regulations? Is one using the ...
(Date:6/19/2019)... LUIS OBISPO, Calif. (PRWEB) , ... June 19, 2019 , ... “We sometimes take out ... brushing and flossing, and regular checkups we seldom think about our teeth unless it’s baby’s ... Our teeth help us chew, speak, smile and have a very important role in our ...
(Date:6/19/2019)... ... ... A new survey by The Senior Citizens League (TSCL) indicates ... If that doesn’t sound like enough of a challenge, at a time when ... spending $1,000 per month or more. The same survey also found that, of ...
Breaking Medicine Technology:
(Date:6/16/2019)... , ... June 15, 2019 , ... All families go ... poverty, untreated mental health needs and lack of a support network, they may be ... to remove the children from the home and place them with a relative, familiar ...
(Date:6/14/2019)... ... June 14, 2019 , ... United Breast Cancer Foundation ... for Saturday, July 13th. UBCF is thrilled to return to the “City of ... cancer. This second event was added after an overwhelming response to the Tempur-Pedic® ...
(Date:6/13/2019)... ... June 13, 2019 , ... Endometriosis is a painful, inflammatory disease that occurs when ... , Painful periods , Heavy bleeding , Irregular menstruation , ... , Women’s Excellence uses the latest and newest treatment protocols in dealing with the ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... 30 Second Test (BL30SEC) has been accepted by the 2019 National Conference of ... Appendix N requirements. , The Charm BL30SEC test was validated by third ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... Hard money ... just 24 hours and the funds can also be provided quickly. If the documentation ... , Private lenders are able to avoid the federal oversight involved with a traditional ...
Breaking Medicine News(10 mins):